GlassScriptPhysician profile
Janine Doneza
NPI 1003129420
$2,521.07
in general payments reported to CMS, 2019-2025
12 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.11 · 2020: $118 · 2021: $785 · 2022: $894 · 2023: $384 · 2024: $81.69 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $332 · Travel and Lodging: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $331.70 |
| Travel and Lodging | $297.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $691.25 | 2022 | |
| Davol INC. | $508.93 | 2020-2021 | |
| Hologic Sales and Service, LLC | $333.38 | 2023-2025 | Acessa Provu System |
| Medical Device Business Services, INC. | $325.00 | 2021 | |
| Aspira Women'S Health INC | $208.26 | 2022-2023 | Ova1 |
| Astellas Pharma US INC | $144.96 | 2024-2025 | Veozah |
| Ethicon US, LLC | $115.48 | 2020-2024 | Harmonic, Ethicon |
| Merck Sharp & Dohme LLC | $94.11 | 2019 | |
| Coopersurgical, INC. | $34.27 | 2022-2025 | Endosee |
| Pacira Pharmaceuticals Incorporated | $31.64 | 2025 | Exparel |
| Therapeuticsmd, INC. | $17.97 | 2021 | |
| Intuitive Surgical, INC. | $15.82 | 2023 | Da Vinci Surgical System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janine Doneza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.